167 results on '"Beems, Megan"'
Search Results
2. ASO Visual Abstract: Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
3. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors
4. Multiple Uses for Procedural Simulators in Continuing Medical Education Contexts
5. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group
6. Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors
7. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?
8. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis
9. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group
10. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group
11. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection
12. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group
13. Race, insurance status, and traumatic brain injury outcomes before and after enactment of the Affordable Care Act
14. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
15. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms
16. Number of rib fractures thresholds independently predict worse outcomes in older patients with blunt trauma
17. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis
18. ASO Visual Abstract: Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
19. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
20. Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis
21. Reply to: Threshold of number of rib fractures in elderly blunt trauma: A simple or complex matter of numbers?
22. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model
23. Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study
24. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors.
25. Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection
26. Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group
27. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors
28. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit
29. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group
30. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence
31. Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy
32. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis
33. Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group
34. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?
35. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors A Multi-institutional and National Data Analysis.
36. Gastric carcinoids: Does type of surgery or tumor affect survival?
37. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
38. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors
39. General Surgery Resident Educational Session Improves Accuracy of Wound Classification
40. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms
41. Optimism/pessimism and health-related quality of life during pregnancy across three continents: a matched cohort study in China, Ghana, and the United States
42. Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda
43. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
44. 413 - Chromogranin a and Predicting Recurrence in Pancreatic Neuroendocrine Tumors: A Novel Pre-Operative Risk Scoring System
45. 343 - Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms
46. Socioeconomic disparities in the thoracic trauma population
47. The conundrum of <2 cm pancreatic neuroendocrine tumors: a preoperative risk score to predict lymph node metastases and guide surgical management
48. Nomogram predicting the risk of recurrence after curative‐intent resection of primary non‐metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group
49. Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: An eight institution study of 695 patients from the U.S. Neuroendocrine Tumor Study Group.
50. Defining the number of lymph nodes needed to accurately stage small bowel neuroendocrine tumors: An 8-institution study from the US neuroendocrine tumor study group.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.